Overview

GSK372475 PK Study in Healthy Volunteers

Status:
Completed

Trial end date:
2008-12-29

Target enrollment:

Participant gender:

Summary

This study will consist of 4 parallel cohorts of healthy volunteers (elderly male, elderly female, young male and young female). Subjects will receive either GSK372475 1.5mg or placebo for 28 days.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline